Stay updated with breaking news from Protein Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global prevalence of HIV, hepatitis, Ebola, and other viral diseases is driving significant market growth in the antiviral drugs market. Furthermore,...
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the second quarter ended December 31, 2022. Second Quarter...
The company reported 1 percent growth in revenues compared to Q2 2022 but said organic revenue growth was 4 percent.
The global prevalence of HIV, hepatitis, Ebola, and other viral diseases is driving significant market growth in the antiviral drugs market. Furthermore, growing viral disease awareness initiatives
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of its ProteinSimple-branded MauriceFlex™ during the WCBP conference in...